Skin manifestations in COVID‐19: The tropics experience

Rerknimitr, Pawinee; Theerawattanawit, Chinathip; Lertpichitkul, Pattamon; Jantarabenjakul, Watsamon; Putcharoen, Opass; Puthanakit, Thanyawee; Panchaprateep, Ratchathorn; Kumtornrut, Chanat; Asawanonda, Pravit

doi:10.1111/1346-8138.15567

Cited by 10 publications

(13 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There were no cases with pseudo-chilblain or livedoid lesions, as reported in other regions, especially Europe [ 17 ]. Only urticaria and maculopapular rash were found in this study, which corresponds with the findings of other studies in tropical countries [ 18 , 19 ]. This might be explained by climate differences and/or a lower severity of COVID-19 infections.…”

Section: Discussionsupporting

confidence: 93%

Patient Recovery from COVID‐19 Infections: Follow‐Up of Hair, Nail, and Cutaneous Manifestations

Thuangtong

Angkasekwinai

Leeyaphan

et al. 2021

BioMed Research International

View full text Add to dashboard Cite

Background. COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. Objective. To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. Methods. A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, and nail abnormalities of patients aged over 18 years who were diagnosed with COVID-19 infections at Siriraj Hospital, Bangkok, Thailand, between January and June 2020. Results. Ninety-three patients with prior COVID-19 infections participated in the study. The COVID-19 severity had been mild for most (71%). Cutaneous manifestations were reported in 8 patients (8.6%), with the common skin conditions being maculopapular rash and urticaria. The onsets of the skin conditions were before admission (1%), during admission (4.3%), and after discharge (3.2%). Increased hair shedding was also reported in 22 patients (23.7%), with a female predominance. Three patients were affected during admission, while the others were affected after discharge. The patients with moderate, severe, and critical COVID-19 infections experienced significantly more hair shedding than those with asymptomatic and mild diseases. Only 2 patients with mild COVID-19 disease reported nail abnormalities (chromonychia and brittle nails). Conclusions. Cutaneous manifestations, hair disorders, and nail abnormalities can occur in patients with COVID-19 after their discharge from hospital. Patients should therefore be followed up in anticipation of dermatological problems.

show abstract

Section: Discussionsupporting

confidence: 93%

Patient Recovery from COVID‐19 Infections: Follow‐Up of Hair, Nail, and Cutaneous Manifestations

Thuangtong

Angkasekwinai

Leeyaphan

et al. 2021

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Two patients with diffuse vesicular eruption were reported in a French study involving both outpatients and inpatients 8 . Vesicular eruptions have been described also in Thailand, in 2 out of 153 patients diagnosed of COVID‐19 9 . A similar rash was described in one patient in Barcelona, whereas 2 out of 130 inpatients evaluated in a hospital in Rome showed herpetiform grouped vesicles.…”

Section: Resultsmentioning

confidence: 84%

“…The latter could have been caused, according to the authors, by human herpes virus 1 or 2 3 . Human herpes virus reactivation would not be surprising among critical inpatients; Hedou et al reported one in an intubated patient with SARS‐CoV‐2 infection, as well as Rerknimitr et al 9,10 A higher incidence of herpes zoster has also been reported 6 …”

Section: Resultsmentioning

confidence: 98%

See 1 more Smart Citation

Six months into the pandemic. A review of skin manifestations in SARS‐CoV ‐2 infection

Burlando

Russo

Cozzani

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

During the COVID‐19 pandemic, various cutaneous manifestations have been described as associated with SARS‐CoV2 infection. It is debated if skin lesions could represent a diagnostic or prognostic indicator. Specifically, it is unclear whether skin lesions may be used to perform an early diagnosis and/or to predict worse outcomes. In this review, we described the cutaneous signs so far reported as COVID‐19‐related and discussed their incidence, clinico‐pathological features, and diagnostic and prognostic value.

show abstract

“…Regarding skin lesions in COVID-19, there are various forms [3]. Sometimes, the lesions are missed diagnosed as other problem [4]. It is necessary that practitioner has to investigate for possible COVID-19 in any patients presenting with unexplained cutaneous lesions.…”

mentioning

confidence: 99%

Cutaneous manifestations of COVID-19

Wiwanitkit¹

2020

Arch Dermatol Res

View full text Add to dashboard Cite

Skin manifestations in COVID‐19: The tropics experience

Cited by 10 publications

References 4 publications

Patient Recovery from COVID‐19 Infections: Follow‐Up of Hair, Nail, and Cutaneous Manifestations

Patient Recovery from COVID‐19 Infections: Follow‐Up of Hair, Nail, and Cutaneous Manifestations

Six months into the pandemic. A review of skin manifestations in SARS‐CoV ‐2 infection

Cutaneous manifestations of COVID-19

Contact Info

Product

Resources

About